Last reviewed · How we verify

NCT04104165

Treatment of Postpartum Urinary Retention

Completed NA Last updated 16 August 2022
What this trial tests

NA trial testing Foley Catheter in Retention, Urinary in 146 participants. Completed in 31 May 2022.

Timeline
1 January 2020
Primary endpoint
30 April 2022
31 May 2022

Quick facts

Lead sponsorRambam Health Care Campus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment146
Start date1 January 2020
Primary completion30 April 2022
Estimated completion31 May 2022
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Adults 18 to 45, female only, with Retention, Urinary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate what is the most effective catheterization duration to resolve covert and overt postpartum urinary retention following vaginal delivery and caesarean delivery, with the highest patients' satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Foley Catheter

Trials testing the same drug.

Other recruiting trials for Retention, Urinary

Currently open trials in the same condition.

Other Rambam Health Care Campus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04104165.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing